Antroquinonol
Antroquinonol is a pharmaceutical drug with 8 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
6
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
7 of 7 finished
0.0%
0 ended early
1
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer
Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients
A Randomized, Double-Blind Trial of Antroquinonol in Patients With Chronic Hepatitis B
Evaluate Efficacy and Safety/Tolerability Profiles of Antroquinonol in Acute Myeloid Leukemia (AML) Adult Patients
Trial of Antroquinonol in Patients With Hypercholesterolemia and Hyperlipidemia
Clinical Trials (8)
Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer
Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients
A Randomized, Double-Blind Trial of Antroquinonol in Patients With Chronic Hepatitis B
Evaluate Efficacy and Safety/Tolerability Profiles of Antroquinonol in Acute Myeloid Leukemia (AML) Adult Patients
Trial of Antroquinonol in Patients With Hypercholesterolemia and Hyperlipidemia
Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC
A Trial of Antroquinonol in Patients With Atopic Dermatitis
Determine MTD and to Evaluate pk, Safety/Tolerability and Efficacy Profiles of Hocena® in NSCLC Subjects
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8